Blog posts by Damon Dierker, OD, FAAO

A 92-year-old patient with intermediate AMD and declining vision raised concern for disease progression. OCT and OCT-A imaging with the Optovue Solix revealed large drusenoid PEDs and pigment migration, but no signs of macular neovascularization or geographic atrophy. This case highlights how non-invasive OCT-A enabled accurate diagnosis and confident management without the need for referral or invasive testing.

In this compelling case study, a 75-year-old woman with intermediate age-related macular degeneration (AMD) and a four-year history of non-exudative macular neovascularization (NE-MNV) is closely monitored using advanced OCT-A technology. Despite her report of increased visual distortion and a subtle increase in lesion size, her condition remained stable without signs of exudation. Through serial imaging, home monitoring, and careful follow-up, the case highlights the power of OCT-A in tracking NE-MNV progression and the importance of vigilance in preventing its conversion to an exudative form. How long can a potentially dangerous lesion remain stable—and might it even play a protective role? Read on to discover how modern imaging and personalized care converge in the nuanced management of AMD.